NeueHealth Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-1,200.6	-1,495.23	-1,184.86	-248.44	-125.34	-62.64
Depreciation & Amortization	24.17	50.58	35.48	8.29	1.13	1.03
Share-Based Compensation	83.69	109.71	68.42	5.45	1.86	0.26
Other Operating Activities	-1,682.95	1,530	1,163	177.46	114.13	34.32
Operating Cash Flow	-2,726.55	234.47	82.06	-57.24	-8.21	-27.03
Operating Cash Flow Growth	-	185.73%	-	-	-	-
Capital Expenditures	-2.9	-27.45	-30.41	-6.47	-0.79	-0.69
Acquisitions	-0.68	-0.31	-431.79	-230.33	-31.86	0
Change in Investments	1,123	-401.97	-90.69	-452.94	-62	-6.25
Investing Cash Flow	1,120	-429.72	-552.89	-689.74	-94.64	-6.94
Share Issuance / Repurchase	0	1.32	898.72	1.24	0.26	0.06
Debt Issued / Paid	66.4	148.95	151.61	0	0	0
Other Financing Activities	-16.49	916.11	-6.69	711.2	423.8	203
Financing Cash Flow	49.91	1,066	1,044	712.44	424.06	203.06
Net Cash Flow	-1,557.01	871.11	572.81	-34.54	321.21	169.08
Free Cash Flow	-2,729.44	207.02	51.65	-63.71	-9	-27.73
Free Cash Flow Growth	-	300.85%	-	-	-	-
Free Cash Flow Margin	-235.13%	27.56%	3.41%	-5.28%	-3.21%	-21.23%
Free Cash Flow Per Share	-343.15	26.31	10.53	-37.42	-5.35	-16.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).